Literature DB >> 22744439

Medical mitigation model: quantifying the benefits of the public health response to a chemical terrorism attack.

Kevin Good1, David Winkel, Michael VonNiederhausern, Brian Hawkins, Jessica Cox, Rachel Gooding, Mark Whitmire.   

Abstract

The Chemical Terrorism Risk Assessment (CTRA) and Chemical Infrastructure Risk Assessment (CIRA) are programs that estimate the risk of chemical terrorism attacks to help inform and improve the US defense posture against such events. One aspect of these programs is the development and advancement of a Medical Mitigation Model-a mathematical model that simulates the medical response to a chemical terrorism attack and estimates the resulting number of saved or benefited victims. At the foundation of the CTRA/CIRA Medical Mitigation Model is the concept of stock-and-flow modeling; "stocks" are states that individuals progress through during the event, while "flows" permit and govern movement from one stock to another. Using this approach, the model is able to simulate and track individual victims as they progress from exposure to an end state. Some of the considerations in the model include chemical used, type of attack, route and severity of exposure, response-related delays, detailed treatment regimens with efficacy defined as a function of time, medical system capacity, the influx of worried well individuals, and medical countermeasure availability. As will be demonstrated, the output of the CTRA/CIRA Medical Mitigation Model makes it possible to assess the effectiveness of the existing public health response system and develop and examine potential improvement strategies. Such a modeling and analysis capability can be used to inform first-responder actions/training, guide policy decisions, justify resource allocation, and direct knowledge-gap studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22744439      PMCID: PMC3657024          DOI: 10.1007/s13181-012-0244-0

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  3 in total

1.  Considerations in developing medical countermeasures against chemical ocular toxicity.

Authors:  David T Yeung; Houmam Araj; Jill R Harper; Gennady E Platoff
Journal:  Toxicol Lett       Date:  2020-09-08       Impact factor: 4.372

2.  Characterization of a nose-only inhaled phosgene acute lung injury mouse model.

Authors:  Jennifer L Plahovinsak; Mark R Perry; Katherine A Knostman; Robert Segal; Michael C Babin
Journal:  Inhal Toxicol       Date:  2015       Impact factor: 2.724

3.  The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people.

Authors:  David T Yeung; Jill R Harper; Gennady E Platoff
Journal:  Drug Dev Res       Date:  2020-06-22       Impact factor: 5.004

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.